Search results for:

Pulmonary hypertension requires early diagnosis and aggressive treatment

The understanding of pulmonary hypertension (PH) continues to evolve. The threshold to diagnose PH was lowered to mPAP ≥ 20 mmHg in the 6th World Symposium on PH in 2018. The therapeutic approach has also changed over time, favoring aggressive use of multiple pulmonary vasodilators in combination upfront and escalation of therapy based frequent assessment of disease progression. The changes to diagnostic criteria and management underscore the need to identify the disease early and to treat it aggressively.  

Read more

Robotic hepatectomy greatly enhances surgical view and access to critical structures, resulting in a safe operation with big benefits to patients

Amar Gupta, MD, FRCS(C), an abdominal transplant and hepatopancreatobiliary surgeon on the medical staff at Baylor University Medical Center, was skeptical about the benefits of the robotic surgical system in complex liver surgeries. He saw it as a gimmick, something that was more industry-driven than something that would offer a real benefit to patients. After a week’s observation of a surgeon in Riyadh, Saudi Arabia, who has performed more than 200 robotic hepatectomies, Dr. Gupta became a true believer in its value.

Read more

Study validates feasibility of using HCV-positive donors in HCV-negative recipients

The opioid epidemic has resulted in thousands of deaths in people infected with acute hepatitis C (HCV) due to IV drug use. Because many of these people are undiagnosed, especially in high-risk populations, many organs from HCV-positive donors are still being procured. The development of highly effective direct-acting antiviral (DAA) therapy has made it possible to successfully transplant HCV-positive organs into HCV-negative recipients and treat the hepatitis C post transplant.

Read more

Uterus Transplant Program expands

Baylor University Medical Center opens access to uterus transplantation

The Uterus Transplant Program at Baylor University Medical Center at Dallas (Baylor Dallas), part of Baylor Scott & White Health, was one of the first programs in the world to study uterus transplantation and has quickly become the largest program in the world. With 20 transplants and 14 healthy babies, the Baylor Dallas Uterus Transplant Program is now the first in the world to offer uterus transplantation outside of a clinical trial.

Read more